AN2 Therapeutics, Inc.

ANTX

$4.20▲ 0.00% 24h

Advanced chart & tools →

AN2 Therapeutics, Inc.ANTX

$4.20

+$2.64(+170.02%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

$150.95M

P/E ratio

—

EPS (diluted)

$-1.16

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

—

Net income

$-35.17M

Net margin

—

Gross margin

—

Dividends & financials

AN2 Therapeutics, Inc. (ANTX) reported revenue of — and net income of $-35.17M, or $-1.16 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.